Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''
- PMID: 27632370
- PMCID: PMC5061903
- DOI: 10.1038/bjc.2016.268
Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''
Comment on
-
The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome.Br J Cancer. 2013 Oct 29;109(9):2396-403. doi: 10.1038/bjc.2013.604. Epub 2013 Oct 10. Br J Cancer. 2013. PMID: 24113143 Free PMC article.
-
Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome'.Br J Cancer. 2016 Oct 11;115(8):e7. doi: 10.1038/bjc.2016.242. Epub 2016 Sep 15. Br J Cancer. 2016. PMID: 27632372 Free PMC article. No abstract available.
References
-
- Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR. (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134(3): 522–529. - PubMed
-
- McCarty MF, Barroso-Aranda J, Contreras F. (2009) Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells. Med Hypotheses 72(3): 330–332. - PubMed
-
- Mekada K, Abe K, Murakami A, Nakamura S, Nakata H, Moriwaki K, Obata Y, Yoshiki A (2009) Genetic differences among C57BL/6 substrains. Exp Anim 58(2): 141–149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources